{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:38:29Z","timestamp":1773772709198,"version":"3.50.1"},"reference-count":30,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1134\/s1607672924700996","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T10:02:02Z","timestamp":1720864922000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Features of ACPA-Negative and ACPA-Positive Variants of Rheumatoid Arthritis"],"prefix":"10.1134","volume":"517","author":[{"given":"D. A.","family":"Dibrov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Avdeeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. V.","family":"Rybakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. V.","family":"Demidova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"7540_CR1","volume-title":"Revmatologiya. Rossiiskie klinicheskie rekomendatsii (Rheumatology. Russian Clinical Recommendations)","year":"2020","unstructured":"Revmatologiya. Rossiiskie klinicheskie rekomendatsii (Rheumatology. Russian Clinical Recommendations), Nasonov, E.L., Ed., Moscow: GEOTAR-Media, 2020. ISBN 978-5-9704-5398-8."},{"key":"7540_CR2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1136\/annrheumdis-2017-211325","volume":"76","author":"L.E. Burgers","year":"2017","unstructured":"Burgers, L.E., Van Steenbergen, H.W., Ten Brinck, R.M., Huizinga, T.W., and Van Der Helm-Van Mil, A.H., Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis, Ann. Rheum. Dis., 2017, vol. 76, no. 10, pp. 1751\u20131754. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211325","journal-title":"Ann. Rheum. Dis."},{"key":"7540_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.55563\/clinexprheumatol\/4bcmdb","volume":"39","author":"E. Pertsinidou","year":"2021","unstructured":"Pertsinidou, E., Manivel, V.A., Westerlind, H., Klareskog, L., Alfredsson, L., Mathsson-Alm, L., Hansson, M., Saevarsdottir, S., Askling, J., and R\u00f6nnelid, J., Rheumatoid arthritis autoantibodies and their association with age and sex, Clin. Exp. Rheumatol., 2021, vol. 39, no. 4, pp. 879\u2013882. https:\/\/doi.org\/10.55563\/clinexprheumatol\/4bcmdb","journal-title":"Clin. Exp. Rheumatol."},{"key":"7540_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13075-017-1324-y","volume":"19","author":"D.M. Boeters","year":"2017","unstructured":"Boeters, D.M., Mangnus, L., Ajeganova, S., Lindqvist, E., Svensson, B., Toes, R.E.M., Trouw, L.A., Huizinga,\u00a0\u00a0\u00a0T.W.J., Berenbaum, F., Morel, J., Rantap\u00e4\u00e4-Dahlqvist, S., and Van Der Helm-Van Mil, A.H.M., The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical, Arthritis Res. Ther., 2017, vol. 19, no. 1, p. 115. https:\/\/doi.org\/10.1186\/s13075-017-1324-y","journal-title":"Arthritis Res. Ther."},{"key":"7540_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/rheumatology\/ket449","volume":"53","author":"M.B. Arnold","year":"2014","unstructured":"Arnold, M.B., Bykerk, V.P., Boire, G., Haraoui, B.P., Hitchon, C., Thorne, C., Keystone, E.C., Pope, J.E., and CATCH Investigators, Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort, Rheumatology (Oxford), 2014, vol.\u00a053, no. 6, pp. 1075\u20131086. https:\/\/doi.org\/10.1093\/rheumatology\/ket449","journal-title":"Rheumatology"},{"key":"7540_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/oarrr.s306378","volume":"13","author":"J. Nilsson","year":"2021","unstructured":"Nilsson, J., Andersson, M., Hafstr\u00f6m, I., Svensson, B., Forslind, K., Ajeganova, S., Leu Agelii, M., and Gjertsson, I., Influence of age and sex on disease course and treatment in rheumatoid arthritis, Open Access Rheumatol.: Res. Rev., 2021, vol. 13, pp. 123\u2013138. https:\/\/doi.org\/10.2147\/oarrr.s306378","journal-title":"Open Access Rheumatol.: Res. Rev."},{"key":"7540_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1186\/ar1767","volume":"7","author":"A.H. Van Der Helm-Van Mil","year":"2005","unstructured":"Van Der Helm-Van Mil, A.H., Verpoort, K.N., Breedveld, F.C., Toes, R.E., and Huizinga, T.W., Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis, Arthritis Res. Ther., 2005, vol. 7, no. 5, pp. 949\u2013958. https:\/\/doi.org\/10.1186\/ar1767","journal-title":"Arthritis Res. Ther."},{"key":"7540_CR8","doi-asserted-by":"publisher","first-page":"r8","DOI":"10.1186\/ar2907","volume":"12","author":"J. Ursum","year":"2010","unstructured":"Ursum, J., Bos, W.H., Van Dillen, N., Dijkmans, B.A., and Van Schaardenburg, D., Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study, Arthritis Res. Ther., 2010, vol. 12, no. 1, p.\u00a0r8. https:\/\/doi.org\/10.1186\/ar2907","journal-title":"Arthritis Res. Ther."},{"key":"7540_CR9","doi-asserted-by":"publisher","unstructured":"Bergstra, S.A., Couto, M.C., Govind, N., Chopra, A., Salomon Escoto, K., Murphy, E., Huizinga, T.W., and Allaart, C.F., Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry, RMD Open, 2019, vol. 5, no. 2, p. e000969. https:\/\/doi.org\/10.1136\/rmdopen-2019-000969","DOI":"10.1136\/rmdopen-2019-000969"},{"key":"7540_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/annrheumdis-2011-200379","volume":"71","author":"M. van den Broek","year":"2012","unstructured":"van den Broek, M., Dirven, L., Klarenbeek, N.B., Molenaar, T., Han, K.H., Kerstens, P., Huizinga, T., Dijkmans, B., and Allaart, C.F., The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study, Ann. Rheum. Dis., 2012, vol. 71, no.\u00a02, pp. 245\u2013248. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200379","journal-title":"Ann. Rheum. Dis."},{"key":"7540_CR11","doi-asserted-by":"publisher","first-page":"r13","DOI":"10.1186\/ar4439","volume":"16","author":"S.D. Seegobin","year":"2014","unstructured":"Seegobin, S.D., Ma, M.H., Dahanayake, Ch., Cope, A.P., Scott, D.L., Lewis, C.M., and Scott, I.C., ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial, Arthritis Res. Ther., 2014, vol. 16, no. 1, p.\u00a0r13. https:\/\/doi.org\/10.1186\/ar4439","journal-title":"Arthritis Res. Ther."},{"key":"7540_CR12","first-page":"646","volume":"23","author":"R. Shpatz","year":"2021","unstructured":"Shpatz, R., Braun-Moscovici, Y., and Balbir-Gurman, A., ACPA antibodies titer at the time of rheumatoid arthritis diagnosis is not associated with disease severity, Isr. Med. Assoc. J., 2021, vol. 23, no. 10, pp. 646\u2013650.","journal-title":"Isr. Med. Assoc. J."},{"key":"7540_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/acr.23497","volume":"70","author":"A.C. Boer","year":"2018","unstructured":"Boer, A.C., Boonen, A., and Van Der Helm Van Mil,\u00a0A.H.M., Is anti\u2013citrullinated protein antibody\u2013positive rheumatoid arthritis still a more severe disease than anti\u2013citrullinated protein antibody\u2013negative rheumatoid arthritis? A longitudinal cohort study in rheumatoid arthritis patients diagnosed from 2000 onward, Arthritis Care Res. (Hoboken), 2018, vol. 70, no.\u00a07, pp. 987\u2013996. https:\/\/doi.org\/10.1002\/acr.23497","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"7540_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/acr.20207","volume":"62","author":"T.M. Farragher","year":"2010","unstructured":"Farragher, T.M., Lunt, M., Plant, D., Bunn, D.K., Barton, A., and Symmons, D.P.M., Benefit of early treatment in inflammatory polyarthritis patients with anti\u2013cyclic citrullinated peptide antibodies versus those without antibodies, Arthritis Care Res. (Hoboken), 2010, vol. 62, no. 5, pp. 664\u2013675. https:\/\/doi.org\/10.1002\/acr.20207","journal-title":"Arthritis Care Res."},{"key":"7540_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13075-019-1909-8","volume":"21","author":"G. Mouterde","year":"2019","unstructured":"Mouterde, G., Rincheval, N., Lukas, C., Daien, C., Saraux, A., Dieud\u00e9, P., Morel, J., and Combe, B., Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort, Arthritis Res. Ther., 2019, vol. 21, no. 1, p. 140. https:\/\/doi.org\/10.1186\/s13075-019-1909-8","journal-title":"Arthritis Res. Ther."},{"key":"7540_CR16","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00296-015-3271-8","volume":"35","author":"W. Katchamart","year":"2015","unstructured":"Katchamart, W., Koolvisoot, A., Aromdee, E., Chiowchanwesawakit, P., and Muengchan, Ch., Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis, Rheumatol. Int., 2015, vol. 35, no. 10, pp. 1693\u20131699. https:\/\/doi.org\/10.1007\/s00296-015-3271-8","journal-title":"Rheumatol. Int."},{"key":"7540_CR17","first-page":"281","volume":"24","author":"N. del Val del Amo","year":"2006","unstructured":"del Val del Amo, N., Ibanez Bosch, R., Fito Manteca, C., Gutierrez Polo, R., and Loza Cortina, E., Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness, Clin. Exp. Rheumatol., 2006, vol. 24, no. 3, pp. 281\u2013286.","journal-title":"Clin. Exp. Rheumatol."},{"key":"7540_CR18","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3899\/jrheum.140082","volume":"41","author":"L. Barra","year":"2014","unstructured":"Barra, L., Pope, J.E., Orav, J.E., Boire, G., Haraoui, B., Hitchon, C., Keystone, E.C., Thorne, J.C., Tin, D., and Bykerk, V.P., Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis, J. Rheumatol., 2014, vol. 41, no. 12, pp.\u00a02361\u20132369. https:\/\/doi.org\/10.3899\/jrheum.140082","journal-title":"J. Rheumatol."},{"key":"7540_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/annrheumdis-2015-208873","volume":"76","author":"L.B. Nordberg","year":"2017","unstructured":"Nordberg, L.B., Lillegraven, S., Lie, E., Aga, A.-B., Olsen, I.Ch., Hammer, H.B., Uhlig, T., Jonsson, M.K., Van Der Heijde, D., Kvien, T.K., and Haavardsholm,\u00a0E.A., Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-na\u00efve patients classified according to the 2010 ACR\/EULAR criteria, Ann. Rheum. Dis., 2017, vol. 76, no. 2, pp. 341\u2013345. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208873","journal-title":"Ann. Rheum. Dis."},{"key":"7540_CR20","doi-asserted-by":"publisher","unstructured":"Choi, S.-T. and Lee, K.-H., Clinical management of seronegative and seropositive rheumatoid arthritis: a comparative study, PLoS One, 2018, vol. 13, no. 4, p.\u00a0e0195550. https:\/\/doi.org\/10.1371\/journal.pone.0195550","DOI":"10.1371\/journal.pone.0195550"},{"key":"7540_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13075-018-1635-7","volume":"20","author":"M.K. Jonsson","year":"2018","unstructured":"Jonsson, M.K., Hensvold, A.H., Hansson, M., Aga,\u00a0A.-B., Sexton, J., Mathsson-Alm, L., Cornillet, M., Serre, G., Lillegraven, S., Fevang, B.-T.S., Catrina, A.I., and Haavardsholm, E.A., The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy, Arthritis Res. Ther., 2018, vol. 20, no. 1, p. 146. https:\/\/doi.org\/10.1186\/s13075-018-1635-7","journal-title":"Arthritis Res. Ther."},{"key":"7540_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00296-021-04931-2","volume":"42","author":"S.S. Zhao","year":"2022","unstructured":"Zhao, S.S., Nikiphorou, E., Young, A., and Kiely, P.D.W., Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status\u2014results from the early rheumatoid arthritis study, Rheumatol. Int., 2022, vol. 42, no. 4, pp. 621\u2013629. https:\/\/doi.org\/10.1007\/s00296-021-04931-2","journal-title":"Rheumatol. Int."},{"key":"7540_CR23","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-019-04602-5","volume":"38","author":"O. Gadeholt","year":"2019","unstructured":"Gadeholt, O., Hausotter, K., Eberle, H., Klink, T., and Pfeil, A., Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis, Clin. Rheumatol., 2019, vol. 38, no. 9, pp. 2403\u20132410. https:\/\/doi.org\/10.1007\/s10067-019-04602-5","journal-title":"Clin. Rheumatol."},{"key":"7540_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00296-019-04492-5","volume":"40","author":"J. Grosse","year":"2020","unstructured":"Grosse, J., Allado, E., Roux, C., Pierreisnard, A., Couderc, M., Clerc-Urmes, I., Remen, T., Albuisson, \u00c9., De Carvalho-Bittencourt, M., Chary-Valckenaere, I., and Loeuille, D., ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography, Rheumatol. Int., 2020, vol. 40, no. 4, pp. 615\u2013624. https:\/\/doi.org\/10.1007\/s00296-019-04492-5","journal-title":"Rheumatol. Int."},{"key":"7540_CR25","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s10067-019-04554-w","volume":"38","author":"Yo Joo","year":"2019","unstructured":"Joo, Yo.B., Park, Y.-J., Park, K.-S., and Kim, K.-J., Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis, Clin. Rheumatol., 2019, vol. 38, no. 9, pp. 2423\u20132432. https:\/\/doi.org\/10.1007\/s10067-019-04554-w","journal-title":"Clin. Rheumatol."},{"key":"7540_CR26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/ard.2003.014233","volume":"63","author":"K. Forslind","year":"2004","unstructured":"Forslind, K., Ahlm\u00e9n, M., Eberhardt, K., Hafstr\u00f6m, I., Svensson, B., and BARFOT Study Group, Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP), Ann. Rheum. Dis., 2004, vol. 63, no.\u00a09, pp. 1090\u20131095. https:\/\/doi.org\/10.1136\/ard.2003.014233","journal-title":"Ann. Rheum. Dis."},{"key":"7540_CR27","first-page":"500","volume":"29","author":"A. Mustila","year":"2011","unstructured":"Mustila, A., Korpela, M., Haapala, A.M., Kautiainen, H., Laasonen, L., and M\u00f6tt\u00f6nen, T., Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies, Clin. Exp. Rheumatol., 2011, vol. 29, no. 3, pp. 500\u2013505.","journal-title":"Clin. Exp. Rheumatol."},{"key":"7540_CR28","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.mayocp.2019.05.023","volume":"94","author":"C.M. Coffey","year":"2019","unstructured":"Coffey, C.M., Crowson, C.S., Myasoedova, E., Matteson, E.L., and Davis, J.M., Evidence of diagnostic and treatment delay in seronegative rheumatoid arthritis: missing the window of opportunity, Mayo Clinic Proc., 2019, vol. 94, no. 11, pp. 2241\u20132248. https:\/\/doi.org\/10.1016\/j.mayocp.2019.05.023","journal-title":"Mayo Clinic Proc."},{"key":"7540_CR29","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1093\/rheumatology\/keaa623","volume":"60","author":"K. Paalanen","year":"2021","unstructured":"Paalanen, K., Puolakka, K., Nikiphorou, E., Hannonen, P., and Sokka, T., Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study, Rheumatology (Oxford), 2021, vol. 60, no. 5, pp.\u00a02391\u20132395. https:\/\/doi.org\/10.1093\/rheumatology\/keaa623","journal-title":"Rheumatology"},{"key":"7540_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/annrheumdis-2017-eular.2332","volume":"37","author":"K. Paalanen","year":"2019","unstructured":"Paalanen, K., Rannio, K., Rannio, T., Asikainen, J., Hannonen, P., and Sokka, T., Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study, Clin. Exp. Rheumatol., 2019, vol.\u00a037, no. 1, pp. 37\u201343. https:\/\/doi.org\/10.1136\/annrheumdis-2017-eular.2332","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672924700996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672924700996","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672924700996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:21:34Z","timestamp":1773760894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672924700996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7540"],"URL":"https:\/\/doi.org\/10.1134\/s1607672924700996","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,13]]},"assertion":[{"value":"12 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Nasonova Research Institute of Rheumatology (protocol no. 22 dated 2 December 2021). Informed consent was obtained from all individual participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}}]}}